Methotrexate adjuvants to reduce toxicity and methods for using the same

摘要

Methods are provided for using methotrexate (MTX) active agents in which reduced host toxicity is observed. Aspects of the methods include administering to a subject an effective amount of an MTX active agent in conjunction with a MTX toxicity-reducing adjuvant, such as a 2,2′-anhydropyrimidine, a derivative thereof or a uridine phosphorylase inhibitor. Also provided are compositions and kits that find use in practicing embodiments of the invention. The methods and compositions find use in a variety of applications, including the treatment of a variety of different disease conditions.

主权项

1. A kit for use in treating a host suffering from a cellular proliferative disease condition, said kit comprising:
(a) an MTX active agent; and (b) an MTX toxicity-reducing adjuvant, wherein said MTX toxicity-reducing adjuvant is a 2,2′-anhydropyrimidine or derivative thereof.